MEI Pharma Secures Over $100 Million Funding Commitment to Launch Litecoin Treasury Strategy
BlockBeats News, July 19th, Titan Partners Group and crypto investment firm GSR are co-leading a strategic transformation of the US pharmaceutical company MEI Pharma (NASDAQ: MEIP), driving the establishment of a dedicated Litecoin treasury strategy. Currently, there has been over $100 million in funding commitments to this project.
It is worth mentioning that Litecoin creator Charlie Lee has agreed to join the MEI Pharma board of directors. Furthermore, the Litecoin Foundation has also invested in MEI Pharma as the company's treasury strategy aligns closely with the Litecoin Foundation's core mission of promoting global Litecoin adoption.
You may also like
Gainers
Latest Crypto News
「Fed Whisperer」: Federal Reserve Chair nominee will meet with Trump this week, nomination may be announced before Christmas
In an Anthropic simulation test, AI Agents discovered a $4.6 million smart contract vulnerability.
The probability of "Bank of Japan 25-basis-point Rate Hike in December" on Polymarket has surged to 81%
Trump to Make Major Announcement Tomorrow at 3 AM
Japanese Government Supports Lowering Cryptocurrency Capital Gains Tax to 20%
Customer Support:@weikecs
Business Cooperation:@weikecs
Quant Trading & MM:bd@weex.com
VIP Services:support@weex.com